FDA Approved: IBANDRONATE SODIUM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves an Original Application for ibandronate sodium as a generic product (Aurobindo Pharma Limited), enabling its use for osteoporosis indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)